BlackRock, Inc. 13D and 13G filings for Stoke Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-07-08 4:32 pm Purchase | 2024-06-30 | 13G | Stoke Therapeutics, Inc. STOK | BlackRock Inc. BLK | 5,409,169 10.400% | 5,409,169 (New Position) | Filing |